Stock Events

Stock Events

Franklin Genomic Advancements 

$41.89
6
-$0.51-1.2% Friday 19:53
-$0.00-0%Friday 22:30After hours

Statistics

Day High
41.89
Day Low
41.76
52W High
43.51
52W Low
29.8
Volume
1,576
Avg. Volume
2,625
Mkt Cap
0
P/E Ratio
-
Dividend Yield
0.34%
Dividend
0.14

Upcoming

Expense Ratio

0.50%
0%
1%+
The annual fee that you pay to the fund company for managing your investment. The lower the expense ratio, the better. This is not an investment recommendation.

Dividends

0.34%Dividend Yield
Jan 26
$0.14
Jan 22
$0.00
Dec 21
$0.11
Dec 20
$0.05
10Y Growth
N/A
5Y Growth
22.59%
3Y Growth
N/A
1Y Growth
N/A

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
ARK Genomic Revolution
ARKG
Mkt Cap0
ARK Genomic Revolution ETF focuses on companies likely to benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments, genomics, and molecular diagnostics, directly competing with HELX's investment focus.
Global X Genomics & Biotechnology
GNOM
Mkt Cap0
Global X Genomics & Biotechnology ETF invests in companies involved in genomics and biotechnology, offering direct competition to HELX by targeting similar advancements and technologies in the genomic space.
iShares Genomics Immunology and Healthcare
IDNA
Mkt Cap0
iShares Genomics Immunology and Healthcare ETF targets companies in the genomics, immunology, and bioengineering sectors, competing with HELX by investing in the rapidly evolving genomics industry.
Principal Healthcare Innovators Index
BTEC
Mkt Cap0
Principal Healthcare Innovators Index ETF focuses on companies that are leading the charge in healthcare innovation, including genomics and biotechnology, positioning it as a competitor to HELX.
Invesco Biotechnology & Genome
PBE
Mkt Cap0
Invesco Dynamic Biotechnology & Genome ETF invests in companies that are principally engaged in the research, development, manufacture, and distribution of various biotechnological products, therapies, and services, including genomic research, competing directly with HELX's focus.
VanEck Biotech
BBH
Mkt Cap0
VanEck Vectors Biotech ETF includes holdings in biotechnology companies involved in the use of biological and genetic knowledge to develop new therapies and products, competing with HELX in the genomic advancements space.
First Trust NYSE Arca Biotechnology Index Fund
FBT
Mkt Cap0
First Trust NYSE Arca Biotechnology Index Fund is composed of firms in the biotechnology sector, which includes genomic research and development, making it a competitor to HELX.
iShares Biotechnology
IBB
Mkt Cap0
iShares Biotechnology ETF offers exposure to U.S. biotechnology and pharmaceutical companies, which includes companies involved in genomic and genetic research, competing with HELX's investment strategy.
State Street SPDR S&P Biotech
XBI
Mkt Cap0
SPDR S&P Biotech ETF provides exposure to the biotech sector, including genomic research and development companies, making it a competitor to HELX.
ALPS Medical Breakthroughs
SBIO
Mkt Cap0
ALPS Medical Breakthroughs ETF invests in companies with one or more drugs in Phase II or Phase III FDA clinical trials, which often include genomic and genetic research companies, positioning it as a competitor to HELX.

Holdings

Regions

Sectors

About

This fund aims to generate substantial capital growth by strategically investing in a diverse array of equity securities. Its portfolio includes companies based within the United States as well as those operating in international markets, encompassing both established and emerging economies. The core investment thesis of the fund centers on companies engaged in genomic advancements. Specifically, it seeks out firms that the investment manager believes are fundamentally dedicated to, or are poised to significantly benefit from, efforts to prolong and enhance the overall quality of life for both humans and animals. This is accomplished by integrating cutting-edge technological and scientific innovations, improvements, and breakthroughs in the field of genomics directly into their business models and operations.
Show more...
CEO
Country
United States
ISIN
US35473P5200

Listings

BATS
US
HELX
BOATS
BOATS
HELX.BOATS

0 Comments

Share your thoughts

FAQ

What is Franklin Genomic Advancements stock price today?▼
The current price of HELX is $41.89 USD — it has decreased by -1.2% in the past 24 hours. Watch Franklin Genomic Advancements stock price performance more closely on the chart.
What is Franklin Genomic Advancements stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on BATS exchange Franklin Genomic Advancements stocks are traded under the ticker HELX.
Is Franklin Genomic Advancements stock price growing?▼
HELX stock has fallen by -0.29% compared to the previous week, the month change is a +1.35% rise, over the last year Franklin Genomic Advancements has showed a +37.61% increase.
Does Franklin Genomic Advancements pay dividends?▼
Yes, HELX dividends are paid annual. The last dividend per share was 0.14 USD. As of today, Dividend Yield (FWD)% is 0.34%.
In which sector is Franklin Genomic Advancements located?▼
Franklin Genomic Advancements operates in the Finance & Payments sector.
When did Franklin Genomic Advancements complete a stock split?▼
Franklin Genomic Advancements has not had any recent stock splits.
Where is Franklin Genomic Advancements headquartered?▼
Franklin Genomic Advancements is headquartered in San Mateo, United States.